Management of patients with early severe pre-eclampsia
dc.contributor.author | Odendaal H.J. | |
dc.date.accessioned | 2011-05-15T16:17:02Z | |
dc.date.available | 2011-05-15T16:17:02Z | |
dc.date.issued | 1996 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Short Survey | |
dc.identifier.citation | Journal of Maternal-Fetal Investigation | |
dc.identifier.citation | 6 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 09396322 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14041 | |
dc.subject | antihypertensive agent | |
dc.subject | dihydralazine | |
dc.subject | labetalol | |
dc.subject | magnesium sulfate | |
dc.subject | methyldopa | |
dc.subject | nifedipine | |
dc.subject | oxprenolol | |
dc.subject | uric acid | |
dc.subject | delivery | |
dc.subject | female | |
dc.subject | fetus heart rate | |
dc.subject | gestational age | |
dc.subject | health care cost | |
dc.subject | human | |
dc.subject | intramuscular drug administration | |
dc.subject | intravenous drug administration | |
dc.subject | maternal mortality | |
dc.subject | oral drug administration | |
dc.subject | preeclampsia | |
dc.subject | prevention | |
dc.subject | priority journal | |
dc.subject | short survey | |
dc.subject | uric acid blood level | |
dc.title | Management of patients with early severe pre-eclampsia | |
dc.type | Short Survey |